LOS ANGELES CAPITAL MANAGEMENT LLC - UTAH MED PRODS INC ownership

UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 92 filers reported holding UTAH MED PRODS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of UTAH MED PRODS INC
ValueSharesWeighting
Q3 2023$495,876
-6.9%
5,766
+0.9%
0.00%0.0%
Q2 2023$532,452
+6.8%
5,713
+8.6%
0.00%0.0%
Q1 2023$498,680
-10.4%
5,262
-5.0%
0.00%
-33.3%
Q4 2022$556,635
+17.9%
5,5370.0%0.00%
+50.0%
Q3 2022$472,000
-0.8%
5,5370.0%0.00%0.0%
Q2 2022$476,000
+43.8%
5,537
+50.1%
0.00%
+100.0%
Q1 2022$331,000
-10.3%
3,6880.0%0.00%0.0%
Q4 2021$369,000
+7.9%
3,6880.0%0.00%
-50.0%
Q3 2021$342,000
-2.8%
3,688
-10.9%
0.00%0.0%
Q2 2021$352,000
-1.7%
4,1380.0%0.00%0.0%
Q1 2021$358,000
+44.4%
4,138
+40.4%
0.00%
+100.0%
Q4 2020$248,000
+5.5%
2,9470.0%0.00%0.0%
Q3 2020$235,000
-0.4%
2,947
+10.6%
0.00%0.0%
Q2 2020$236,0002,6650.00%
Other shareholders
UTAH MED PRODS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Penn Mutual Asset Management 36,283$3,120,3382.93%
Clean Yield Group 31,263$2,684,5541.19%
BARD ASSOCIATES INC 18,181$1,563,5660.65%
RICE HALL JAMES & ASSOCIATES, LLC 111,634$9,600,5240.61%
Ranger Investment Management 74,411$6,399,3460.42%
ISTHMUS PARTNERS, LLC 21,307$1,832,4020.26%
Cardinal Capital Management 11,581$999,3440.20%
Riverwater Partners LLC 2,354$202,4440.18%
GLOBEFLEX CAPITAL L P 9,338$803,0680.09%
JAMES INVESTMENT RESEARCH INC 4,292$369,1120.05%
View complete list of UTAH MED PRODS INC shareholders